Factors Affecting the Diagnostic Discordance Between Frozen and Permanent Sections in Mucinous Ovarian Tumors
DOI: https://doi.org/10.2147/ijwh.s458138
2024-05-18
International Journal of Women s Health
Abstract:Hua Shao, 1, &ast Na Wang, 2, &ast Guoyan Liu 3, 4, &ast 1 Clinical Psychology Department, Tianjin Medical University General Hospital, Tianjin, People's Republic of China; 2 Gynecology and Obstetrics Department, Tianjin Haihe Hospital, Tianjin, People's Republic of China; 3 Gynecology and Obstetrics Department, Tianjin Medical University General Hospital, Tianjin, People's Republic of China; 4 Gynaecological Oncology Department, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China &astThese authors contributed equally to this work Correspondence: Guoyan Liu, Tel +86 15510993428, Email Purpose: To investigate the accuracy of intraoperative frozen section (FS) diagnosis for predicting the permanent section (PS) diagnosis of mucinous ovarian tumors and evaluate the factors affecting the diagnostic discordance. Patients and Methods: This retrospective cohort study was performed in Tianjin Medical University General Hospital. All women who underwent ovarian surgery with FS between January 2011 and December 2022 were identified, and those with a diagnosis of mucinous ovarian tumor (MOT) by FS or PS were reviewed. Clinical and pathologic data were extracted. Results: A total of 180 women were included, of which 141 (78.33%) had diagnostic concordance between FS and PS, yielding a sensitivity of 83.43% and a positive predictive value (PPV) of 92.76%. Under- and over-diagnosis occurred in 28 cases (15.56%) and 11 cases (6.11%). Tumor size > 13cm (OR 3.79, 95% CI 1.12– 12.73) was an independent risk factor for under-diagnosis, and tumor size ≤ 13cm (OR 16.78, 95% CI 0.01– 0.49), laparoscopic surgery (OR 0.14, 95% CI 0.02– 0.92), the combination of other tumor components (including serous, Brenner tumor, and chocolate cyst; OR 7.00, 95% CI 1.19– 41.12) were independently associated with over-diagnosis. The Kaplan-Meier survival curves and the Log rank test showed no significant difference between misdiagnosed and accurately diagnosed patients (all P > 0.05). Conclusion: Intraoperative frozen pathology of MOT is problematic for under- and over-diagnosis. The incorrect diagnosis of FS was related to determining the extent of surgery but had no impact on the patients' long-term recurrence and survival outcomes. In future clinical practice, surgeons need to obtain material accurately and enhance communication with pathologists during the operation to improve the accuracy of FS diagnosis. Keywords: mucinous ovarian tumors, frozen section, diagnosis Ovarian mucinous tumors (MOT) occur in 10–15% of all ovarian tumors 1 and represent a heterogeneous group of neoplasms, of which benign cystadenomas constitute about 80%, borderline tumors are 10–15%, and less than 10% are malignant tumors. 2–4 The five-year survival rate of borderline mucinous ovarian tumors has been reported to be as high as 100%; however, it is also affected by the length of the follow-up period, and up to 13% of patients with borderline tumors progress to carcinoma within ten years. 5–7 Surgical treatment is the primary treatment modality, and surgical approaches and extent of resection vary based on tumor pathology. 8,9 Ultrasound is the initial and preferred imaging modality used for MOT, and it can be complemented by magnetic resonance imaging (MRI). 10,11 However, high-quality images cannot be obtained due to abdominal gas, making the identification of ovarian tumors challenging. Several tumor markers are commonly used to evaluate patients with ovarian cancer, including CA125, CA199, CA153, HE4, CEA, and AFP. 12 In particular, CA199 is a sensitive indicator for diagnosing MOT, primarily associated with borderline and malignant tumors, and can be used as a complementary marker to identify benign, borderline, or malignant MOT. 13 The combined testing of multiple indicators can increase diagnostic accuracy, but the preoperative diagnosis of MOT is difficult due to the low specificity and sensitivity. 14–18 Intraoperative frozen section (FS) is a common and effective examination with the advantage that the pathologic results can be obtained at the time of surgery so that the surgical procedure and extent of surgery can be determined. 19 Surgery and chemotherapy are the basis of ovarian cancer treatment, and the specific treatment plan varies according to the pathologic stage of MOT. 20 Primary treatment for stage I patients consists of complete staging surgery and postoperative therapy, and an appendix with an abnormal appearance should be removed. Observation is usually adequate after surgery -Abstract Truncated-
obstetrics & gynecology